The filing is a routine insider intent-to-sell notice for a small number of shares. No material impact expected. Monitor for actual sale execution on Form 4, but this is unlikely to signal any change in company outlook.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $386.00entry
- T+1 · 5d ago −4.02%α −3.67% · $370.48
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Courtney Enloe, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 902 shares of common stock, with an approximate market value of $348,320.83 based on a filing date price of ~$386. The shares were acquired through restricted stock vesting in September 2026. The sale is small relative to the company's $10.3B market cap and the insider's likely total holdings, making it a routine diversification event.
Key Facts
- Courtney Enloe (Officer) filed Form 144 to sell 902 shares of Bio-Rad common stock.
- Estimated aggregate market value of the proposed sale is $348,320.83.
- Shares were acquired via restricted stock vesting on 09/05/2026 (439 shares) and 09/06/2026 (463 shares).
- The proposed sale date is 11/10/2026, the same day as the filing.
- The sale represents approximately 0.003% of Bio-Rad's $10.3B market cap.
Financial Impact
Proposed sale of 902 shares valued at ~$348,321, representing a negligible fraction of market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- Insider selling, even small, can sometimes precede broader selling by other insiders, but no pattern is evident here.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010973 |
| Document: 0001950047-26-010973-index.html | 0001950047-26-010973 |
| Document: 0001950047-26-010973.txt | 0001950047-26-010973 |
Track record
9 reports on BIO
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $370.48 Now $360.26 −2.76% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $386.00 Now $360.26 −6.67% settles Nov 18
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $386.48 Now $360.26 −6.78% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $386.48 Now $360.26 −6.78% settles Nov 17
- Nov 6, 202610d ago Institutional Cluster Bearish 4/10 Entry $388.31 to $360.26 Now $360.26 +7.22% ▲ +7.22% +5.53% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $369.00 to $370.48 Now $360.26 −2.37% ▲ +0.40% −2.89% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $385.12 to $379.99 Now $360.26 −6.46% ▼ −1.33% −0.62% vs SPY
- Sep 10, 20269w ago Court Ruling Bearish 5/10 Entry $369.32 to $376.41 Now $360.26 +2.45% ▼ −1.92% −2.26% vs SPY
- Jun 12, 202622w ago Institutional Cluster Mixed 5/10 Entry $285.94 to $282.44 Now $360.26 +25.99% ▼ −1.22% −1.90% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers